MENU
SEP 17, 2020 4:30 PM PDT

Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Chief Commercial Officer, Molecular Biology Systems, BV
    Biography

      Brian McNally joined Molecular Biology Systems (MBS) as Chief Commercial Officer after 12 years in the life science and diagnostic industry. Previously, Brian has commercialized numerous nucleic acid, protein and cell-based assays for leading technology providers, many focused on multiplex panels for infectious and genetic diseases. Brian has fifteen years of practical experience at the laboratory bench, and his work has been published and presented at international conferences. Brian has a BSC from Carnegie Mellon University and a doctorate in Cell & Molecular Biology from University of Texas Southwestern.


    Abstract

    The COVID-19 pandemic has resulted in demand for population scale pathogen screening. The most sensitive and reliable method for detecting SARS-CoV-2 remains reverse transcription PCR (RT-PCR). However, current platforms for SARS-CoV-2 RNA detection have not yet met the demand for large scale, rapid testing. Here, we present an ultra-fast PCR platform, NEXTGENPCR, which accelerates RT-PCR assays. The NEXTGENPCR machine provides a small footprint capable of running PCR in 96 or 384 well plates in less than 10 minutes; and RT-PCR in less than 16 minutes. Come learn how you can accelerate RT-PCR for direct detection or sequencing applications.

    Learning Objectives:

    1. Understand how NEXTGENPCR accelerates SARS-CoV-2 assays and chemistries

    2. Considerations for setting up an efficient workflow to process >1,000 per hour

    3. Understand how accelerated cycling yields equivalent assay performance


    Show Resources
    You May Also Like
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 17, 2020 2:00 PM PDT
    C.E. CREDITS
    SEP 17, 2020 2:00 PM PDT
    Learning Objectives: 1. Understanding the integral value of collaboration for advancement in scientific research; how to establish and grow academic, Pharma, and industry connections 2. Lear...
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    Loading Comments...
    Show Resources
    Attendees
    • See more